Nautilus Biotechnology Appoints Proteomics Commercial Leader Amber Faust as Vice President of Sales
Nautilus Biotechnology, Inc. (NAUT)
Company Research
Source: GlobeNewswire
SEATTLE, March 02, 2026 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT), a company pioneering single-molecule proteome analysis, today announced the appointment of Amber Faust as Vice President of Sales. Ms. Faust joins Nautilus following the public debut of the Nautilus Voyager™ Platform, designed to deliver and scale Iterative Mapping, a method that enables single-molecule analysis of proteins and proteoforms across the proteome. Ms. Faust brings nearly two decades of commercial leadership experience in life sciences, with a focus on advancing adoption of emerging proteomics technologies across pharmaceutical, biotechnology, academic, clinical, and government sectors. She has held roles of increasing responsibility at proteomics companies including Olink Proteomics, SomaLogic, and Waters Corporation. "We are pleased to bring on Amber as our first sales hire to take on a major role in introducing the Nautilus VoyagerTM Platform to the market," said Sujal Patel,
Show less
Read more
Impact Snapshot
Event Time:
NAUT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NAUT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NAUT alerts
High impacting Nautilus Biotechnology, Inc. news events
Weekly update
A roundup of the hottest topics
NAUT
News
- Nautilus Biotechnology (NAUT) had its price target raised by Guggenheim from $2.50 to $4.00. They now have a "buy" rating on the stock.MarketBeat
- Nautilus Biotechnology Q4 Earnings Call Highlights [Yahoo! Finance]Yahoo! Finance
- Nautilus Biotechnology Reports Fourth Quarter and Fiscal Year 2025 Financial ResultsGlobeNewswire
- Nautilus Biotechnology Unveils Voyager Platform, Enabling Single-Molecule Iterative Mapping, at US HUPO 2026GlobeNewswire
- Nautilus Biotechnology to Participate in the TD Cowen 46th Annual Health Care Conference [Yahoo! Finance]Yahoo! Finance
NAUT
Earnings
- 4/29/25 - Beat
NAUT
Sec Filings
- 3/4/26 - Form SCHEDULE
- 3/4/26 - Form SCHEDULE
- 3/4/26 - Form 4
- NAUT's page on the SEC website